Financials
- Market Capitalization 19.25 M
- Employee 8
- Founded 2021
- CEO N/A
- Website www.allarity.com
- Headquarter Delaware, United States
- FIGI BBG012NXCZP8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.38
ratio cours/chiffre d'affaires
48.53
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4637 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.26 USD | -5.83% | -10.32% | -9.96% | +140.43% | 19.46 M USD | ||
| 4638 | LPCN Lipocine Inc. - Common Stock | 2.36 USD | +0.43% | -5.22% | +4.42% | -18.62% | 19.46 M USD | ||
| 4643 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.68 USD | +11.48% | +47.83% | +51.11% | -80.57% | 19.04 M USD | ||
| 4646 | NCEL NewcelX Ltd. - Ordinary Shares | 3.92 USD | -2.00% | 0.00% | +18.79% | -22.83% | 18.81 M USD |